Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 70, 2010 - Issue 6
Submit an article Journal homepage
357
Views
10
CrossRef citations to date
0
Altmetric
Research Article

C-peptide in dried blood spots

Jesper Johansson Unit for Diabetes and Celiac Disease, Department of Clinical Sciences, Lund University, Wallenberg Laboratory, University Hospital MAS, Malmö
,
Charlotte Becker Department of Clinical Chemistry, University Hospital MAS, Malmö
,
Nils-Göran Persson Department of Clinical Chemistry, University Hospital MAS, Malmö
,
Malin Fex Unit for Diabetes and Celiac Disease, Department of Clinical Sciences, Lund University, CRC, University Hospital MAS, Malmö, Sweden
&
Carina Törn Unit for Diabetes and Celiac Disease, Department of Clinical Sciences, Lund University, Wallenberg Laboratory, University Hospital MAS, MalmöCorrespondence[email protected]
Pages 404-409 | Received 05 Aug 2009, Accepted 28 May 2010, Published online: 05 Jul 2010

References

  • Melani F, Rubenstein AH, Oyer PE, Steiner DF. Identification of proinsulin and C-peptide in human serum by a specific immunoassay. Proc Natl Acad Sci USA 1970;67: 148–55.
  • Torn C. C-peptide and autoimmune markers in diabetes. Clin Lab 2003;49:1–10.
  • Thunander M, Petersson C, Jonzon K, Fornander J, Ossiansson B, Torn C, Edvardsson S, Landin-Olsson M. Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden. Diabetes Res Clin Pract 2008;82:247–55.
  • Vauhkonen I, Niskanen L, Knip M, Ilonen J, Vanninen E, Kainulainen S, Uusitupa M, Laakso M. Impaired insulin secretion in non-diabetic offspring of probands with latent autoimmune diabetes mellitus in adults. Diabetologia 2000; 43:69–78.
  • Cnop M, Vidal J, Hull RL, Utzschneider KM, Carr DB, Schraw T, Scherer PE, Boyko EJ, Fujimoto WY, Kahn SE. Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes. Diabetes Care 2007;30:677–82.
  • Palmer JP. C-peptide in the natural history of type 1 diabetes. Diabetes Metab Res Rev 2009;25:325–8.
  • Sosenko JM, Krischer JP, Palmer JP, Mahon J, Cowie C, Greenbaum CJ, Cuthbertson D, Lachin JM, Skyler JS. A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1. Diabetes Care 2008;31:528–33.
  • Torn C, Landin-Olsson M, Ostman J, Schersten B, Arnqvist H, Blohme G, Bjork E, Bolinder J, Eriksson J, Littorin B, Nystrom L, Sundkvist G, Lernmark A. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds. Diabetes Metab Res Rev 2000;16:442–7.
  • Ludvigsson J. Therapy with GAD in diabetes. Diabetes Metab Res Rev 2009;25:307–15.
  • Little RR, Rohlfing CL, Tennill AL, Madsen RW, Polonsky KS, Myers GL, Greenbaum CJ, Palmer JP, Rogatsky E, Stein DT. Standardization of C-peptide measurements. Clin Chem 2008;54:1023–6.
  • Wasserfall C, Atkinson M, Jodoin E, Schatz D, She JX, Henderson LO, Ellis T. Glutamic acid decarboxylase and IA-2 autoantibodies in type 1 diabetes: comparing sample substrates for autoantibody determinations. Pediatr Diabetes 2000;1:10–6.
  • Bazzigaluppi E, Bonfanti R, Bingley PJ, Bosi E, Bonifacio E. Capillary whole blood measurement of islet autoantibodies. Diabetes Care 1999;22:275–9.
  • Larsson HE, Lynch K, Lernmark B, Nilsson A, Hansson G, Almgren P, Lernmark A, Ivarsson SA. Diabetes-associated HLA genotypes affect birthweight in the general population. Diabetologia 2005;48:1484–91.
  • Butter NL, Hattersley AT, Clark PM. Development of a bloodspot assay for insulin. Clin Chim Acta 2001;310: 141–50.
  • Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307–10.
  • Bland JM, Altman DG. Applying the right statistics: analyses of measurement studies. Ultrasound Obstet Gynecol 2003;22:85–93.
  • Torn C, Landin-Olsson M, Schersten B. Predictability of C-peptide for autoimmune diabetes in young adult diabetic patients. Pract Diab Int 2001;18:83–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.